Drug LitigationDigitek ( Digoxin )

July 24, 2008

Digitek (digoxin) is a drug that was intended to assist or help people in stabilizing their heart beat. Digitek has been used to treat conditions such as congestive heart failure and atrial fibrillation/atrial flutter (types of fast heartbeats).

The product is made by Totowa LLC and distributed by Mylan Pharmaceuticals Inc., under a “Bertek” label and by UDL Laboratories, Inc., under a “UDL” label.

On April 28, 2008, the U.S. Food and Drug Administration recalled the drug due to potential safety risks. In some instances, Digitek could contain twice the approved level of active ingredient needed.

Serious side effects are:

• Nausea
• Vomiting
• Dizziness
• Low Blood Pressure
• Cardiac instability
• Slow heart beat
• Death

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy